CDC25 Phosphatase Inhibitors: An Update

E-ISSN： 1875-5607|12|1|62-73

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.12, Iss.1, 2012-01, pp. : 62-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell Division Cycle 25 (Cdc25) Phosphatase Inhibitors as Antitumor Agents

Drug Design Reviews - Online, Vol. 1, Iss. 2, 2004-04 ,pp. : 123-132

Bentham Science Publishers

Access to resources Recommend Favorite

CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy

Current Medicinal Chemistry, Vol. 16, Iss. 15, 2009-05 ,pp. : 1831-1849

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Small Molecule Cdc25 Phosphatases Inhibitors

Current Medicinal Chemistry, Vol. 15, Iss. 6, 2008-03 ,pp. : 573-580

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review

By Lavecchia Antonio Di Giovanni Carmen Novellino Ettore

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 405-425

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of the interaction between the CDC25 phosphatase cell cycle activator and the 14.3.3 proteins

By Ducommun B.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 105-107

Informa Healthcare

Access to resources Recommend Favorite